Ritter Daniher Financial Advisory’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$42.9K Hold
895
0.01% 288
2026
Q1
$32.9K Hold
895
0.01% 310
2025
Q4
$45.5K Buy
895
+677
+311% +$34.6K 0.01% 279
2025
Q3
$12.1K Sell
218
-132
-38% -$7.73K ﹤0.01% 311
2025
Q2
$24.2K Hold
350
0.01% 218
2025
Q1
$24.3K Hold
350
0.01% 208
2024
Q4
$30.1K Hold
350
0.01% 188
2024
Q3
$41.7K Hold
350
0.01% 173
2024
Q2
$50K Hold
350
0.02% 152
2024
Q1
$44.9K Hold
350
0.01% 157
2023
Q4
$36.2K Hold
350
0.01% 167
2023
Q3
$31.8K Hold
350
0.01% 165
2023
Q2
$28.3K Hold
350
0.01% 164
2023
Q1
$27.9K Buy
+350
New +$24.8K 0.01% 164

Other funds holding NVO

Ritter Daniher Financial Advisory's NVO Position: Q2 2026 in Review

Ritter Daniher Financial Advisory held its Novo Nordisk (NVO) position steady in Q2 2026 at 895 shares worth $42.9K. The position accounts for 0.01% of the portfolio, ranked #288.

Ritter Daniher Financial Advisory first reported a position in NVO in Q1 2023 and has held it in 14 quarters since. The position peaked at $50K in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Ritter Daniher Financial Advisory held 895 shares of Novo Nordisk worth $42.9K as of Q2 2026.
  • Ritter Daniher Financial Advisory left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.01% of Ritter Daniher Financial Advisory's portfolio in Q2 2026, its #288 holding.
  • Ritter Daniher Financial Advisory first reported a position in Novo Nordisk in Q1 2023 and has held it in 14 quarters since.
  • Ritter Daniher Financial Advisory's Novo Nordisk position peaked at $50K in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Ritter Daniher Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.